Europe Diabetic Foot Ulcer Treatment Market Size & Outlook
Europe diabetic foot ulcer treatment market, 2018-2030 (US$M)
Related Markets
Europe diabetic foot ulcer treatment market highlights
- The Europe diabetic foot ulcer treatment market generated a revenue of USD 1,667.7 million in 2023.
- The market is expected to grow at a CAGR of 5.7% from 2024 to 2030.
- In terms of segment, biologics was the largest revenue generating treatment in 2023.
- Biologics is the most lucrative treatment segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 1,667.7 million |
| Market revenue in 2030 | USD 2,465.8 million |
| Growth rate | 5.7% (CAGR from 2023 to 2030) |
| Largest segment | Biologics |
| Fastest growing segment | Biologics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
| Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
Other key industry trends
- In terms of revenue, Europe region accounted for 32.1% of the global diabetic foot ulcer treatment market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,666.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetic Foot Ulcer Treatment Market Scope
Diabetic Foot Ulcer Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe diabetic foot ulcer treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.46% in 2023. Horizon Databook has segmented the Europe diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
Europe diabetic foot ulcer treatment market is driven by factors such as high disposable income, presence of well-established healthcare infrastructure, and availability of skilled professionals. Moreover, presence of favorable reimbursement coverage has increased the adoption of diabetes care & treatment.
In addition, increasing geriatric population and rising cases of diabetes are also anticipated to drive the market. Increasing prevalence of diabetes and rising awareness about diabetes management & control are expected to contribute to the growth of this market over the forecast period.
According to International Diabetes Federation report of 2021, approximately 61 million people in Europe suffered from diabetes, which accounted for around 1 in 11 adults. Russian Federation, Germany, Turkey, Spain, and Italy are the top five countries in the European region with a high prevalence of diabetes.
Reasons to subscribe to Europe diabetic foot ulcer treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe diabetic foot ulcer treatment market databook
-
Our clientele includes a mix of diabetic foot ulcer treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe diabetic foot ulcer treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Europe diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe diabetic foot ulcer treatment market size, by country, 2018-2030 (US$M)
Europe Diabetic Foot Ulcer Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
